Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

Psychosocial support determined by adaptive treatment algorithm

Participants assigned to the adaptive intervention condition will be scheduled for buprenorphine medication management appointments according to the clinic protocol described above for TAU. The adjunctive psychosocial treatment that participants in this condition receive are (1) CBT delivered by behavioral health specialists and/or (2) peer support delivered by certified recovery specialist. The active intervention period will span 3 months post-study entry. Participants will continue to receive TAU following the active intervention period.

Trial Locations (2)

19121

Project HOME Stephen J. Klein Wellness Center, Philadelphia

19123

PHMC Care Clinic, Philadelphia

All Listed Sponsors
collaborator

Philadelphia College of Osteopathic Medicine

OTHER

collaborator

University of Pennsylvania

OTHER

lead

Public Health Management Corporation

OTHER

NCT04650386 - Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients | Biotech Hunter | Biotech Hunter